[Increased risk of infection with biological immunomodifying antirheumatic agents. Clear guidelines are necessary as shown by case reports]
2005 (Swedish)In: Lakartidningen, ISSN 0023-7205, Vol. 102, no 49, 3794-6, 3799 p.Article in journal (Other scientific) Published
Place, publisher, year, edition, pages
2005. Vol. 102, no 49, 3794-6, 3799 p.
Adult, Aged, Antibodies; Monoclonal/*adverse effects, Antirheumatic Agents/*adverse effects, Comparative Study, English Abstract, Escherichia coli Infections/etiology/immunology, Fatal Outcome, Female, Humans, Immunoglobulin G/*adverse effects, Immunosuppressive Agents/*adverse effects, Legionellosis/etiology/immunology, Male, Meningitis; Listeria/etiology/immunology, Middle Aged, Neoplasm Proteins/adverse effects, Opportunistic Infections/etiology/immunology/*microbiology, Pneumonia; Pneumocystis/etiology/immunology, Receptors; Tumor Necrosis Factor, Receptors; Tumor Necrosis Factor; Type II, Risk Factors, Sepsis/etiology/immunology/microbiology, Sialoglycoproteins/*adverse effects, Tuberculosis/etiology/immunology
IdentifiersURN: urn:nbn:se:uu:diva-79449PubMedID: 16408703OAI: oai:DiVA.org:uu-79449DiVA: diva2:107362